Protein provision during critical illness
- PMID: 39153799
- DOI: 10.1016/S0140-6736(24)01499-5
Protein provision during critical illness
Conflict of interest statement
CS has received consulting fees; travel compensation; and honoraria for lectures, presentations, or educational events from Fresenius Kabi, Baxter, Abiomed, and B Braun. CS has also received financial support for an investigator-initiated study from Fresenius Kabi. WHH has received support for attending meetings and travel from Fresenius Kabi and their institution has received a grant from Fresenius Kabi.
Comment on
-
Effect of high versus standard protein provision on functional recovery in people with critical illness (PRECISe): an investigator-initiated, double-blinded, multicentre, parallel-group, randomised controlled trial in Belgium and the Netherlands.Lancet. 2024 Aug 17;404(10453):659-669. doi: 10.1016/S0140-6736(24)01304-7. Lancet. 2024. PMID: 39153816 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
